DexCom Debt to Equity Ratio 2010-2025 | DXCM
DexCom Debt/Equity Ratio Historical Data | |||
---|---|---|---|
Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
2025-03-31 | $4.49B | $2.27B | 1.98 |
2024-12-31 | $4.38B | $2.10B | 2.08 |
2024-09-30 | $4.38B | $1.98B | 2.21 |
2024-06-30 | $4.37B | $2.43B | 1.79 |
2024-03-31 | $4.24B | $2.25B | 1.89 |
2023-12-31 | $4.20B | $2.07B | 2.03 |
2023-09-30 | $4.33B | $2.27B | 1.91 |
2023-06-30 | $4.72B | $2.10B | 2.25 |
2023-03-31 | $3.28B | $2.23B | 1.47 |
2022-12-31 | $3.26B | $2.13B | 1.53 |
2022-09-30 | $3.08B | $1.83B | 1.69 |
2022-06-30 | $2.96B | $2.26B | 1.31 |
2022-03-31 | $2.87B | $2.19B | 1.31 |
2021-12-31 | $2.89B | $2.04B | 1.42 |
2021-09-30 | $2.64B | $2.14B | 1.24 |
2021-06-30 | $2.51B | $2.00B | 1.26 |
2021-03-31 | $2.49B | $1.90B | 1.31 |
2020-12-31 | $2.46B | $1.83B | 1.35 |
2020-09-30 | $2.33B | $1.50B | 1.56 |
2020-06-30 | $2.17B | $1.35B | 1.60 |
2020-03-31 | $1.51B | $0.94B | 1.62 |
2019-12-31 | $1.51B | $0.88B | 1.71 |
2019-09-30 | $1.42B | $0.76B | 1.86 |
2019-06-30 | $1.38B | $0.69B | 2.00 |
2019-03-31 | $1.31B | $0.67B | 1.95 |
2018-12-31 | $1.25B | $0.66B | 1.89 |
2018-09-30 | $0.55B | $0.56B | 0.98 |
2018-06-30 | $0.53B | $0.48B | 1.09 |
2018-03-31 | $0.48B | $0.42B | 1.13 |
2017-12-31 | $0.49B | $0.42B | 1.16 |
2017-09-30 | $0.46B | $0.38B | 1.20 |
2017-06-30 | $0.44B | $0.35B | 1.25 |
2017-03-31 | $0.19B | $0.28B | 0.68 |
2016-12-31 | $0.12B | $0.28B | 0.42 |
2016-09-30 | $0.10B | $0.26B | 0.38 |
2016-06-30 | $0.09B | $0.25B | 0.35 |
2016-03-31 | $0.07B | $0.23B | 0.30 |
2015-12-31 | $0.07B | $0.22B | 0.32 |
2015-09-30 | $0.06B | $0.19B | 0.33 |
2015-06-30 | $0.05B | $0.17B | 0.28 |
2015-03-31 | $0.04B | $0.15B | 0.27 |
2014-12-31 | $0.04B | $0.14B | 0.32 |
2014-09-30 | $0.04B | $0.12B | 0.39 |
2014-06-30 | $0.04B | $0.10B | 0.40 |
2014-03-31 | $0.04B | $0.09B | 0.39 |
2013-12-31 | $0.04B | $0.08B | 0.46 |
2013-09-30 | $0.04B | $0.08B | 0.47 |
2013-06-30 | $0.03B | $0.07B | 0.42 |
2013-03-31 | $0.03B | $0.07B | 0.34 |
2012-12-31 | $0.03B | $0.08B | 0.38 |
2012-09-30 | $0.02B | $0.08B | 0.28 |
2012-06-30 | $0.02B | $0.09B | 0.21 |
2012-03-31 | $0.02B | $0.10B | 0.19 |
2011-12-31 | $0.02B | $0.11B | 0.15 |
2011-09-30 | $0.02B | $0.11B | 0.14 |
2011-06-30 | $0.02B | $0.12B | 0.12 |
2011-03-31 | $0.01B | $0.05B | 0.25 |
2010-12-31 | $0.02B | $0.06B | 0.27 |
2010-09-30 | $0.02B | $0.04B | 0.54 |
2010-06-30 | $0.02B | $0.04B | 0.48 |
2010-03-31 | $0.02B | $0.05B | 0.46 |
2009-12-31 | $0.07B | $-0.02B | -3.55 |
2009-09-30 | $0.06B | $-0.01B | -6.93 |
2009-06-30 | $0.06B | $0.00B | 31.93 |
2009-03-31 | $0.06B | $0.02B | 4.14 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $35.035B | $4.033B |
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $182.012B | 22.03 |
Intuitive Surgical (ISRG) | United States | $178.116B | 73.83 |
Edwards Lifesciences (EW) | United States | $47.204B | 31.31 |
IDEXX Laboratories (IDXX) | United States | $46.087B | 52.96 |
Alcon (ALC) | Switzerland | $45.102B | 30.48 |
IQVIA Holdings (IQV) | United States | $33.074B | 18.69 |
Mettler-Toledo (MTD) | United States | $26.313B | 31.29 |
STERIS (STE) | Ireland | $22.465B | 24.74 |
Waters (WAT) | United States | $18.043B | 25.46 |
SONOVA HOLDING (SONVY) | Switzerland | $17.167B | 0.00 |
Hologic (HOLX) | United States | $14.717B | 15.99 |
Sysmex ADR (SSMXY) | Japan | $10.575B | 30.00 |
Penumbra (PEN) | United States | $8.797B | 64.71 |
Masimo (MASI) | United States | $8.618B | 31.79 |
Globus Medical (GMED) | United States | $7.316B | 17.43 |
Glaukos (GKOS) | United States | $5.358B | 0.00 |
Teleflex (TFX) | United States | $5.103B | 8.42 |
Integer Holdings (ITGR) | United States | $3.826B | 19.09 |
TransMedics (TMDX) | United States | $3.546B | 77.08 |
PROCEPT BioRobotics (PRCT) | United States | $2.979B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.399B | 14.28 |
Nihon Kohden (NHNKY) | Japan | $2.020B | 23.17 |
Elekta AB (EKTAY) | Sweden | $1.937B | 17.41 |
Veracyte (VCYT) | United States | $1.916B | 26.89 |
Alphatec Holdings (ATEC) | United States | $1.590B | 0.00 |
Artivion (AORT) | United States | $1.345B | 126.00 |
Tandem Diabetes Care (TNDM) | United States | $1.112B | 0.00 |
OPKO Health (OPK) | United States | $1.071B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $0.999B | 5.31 |
Pulse Biosciences (PLSE) | United States | $0.990B | 0.00 |
SiBone (SIBN) | United States | $0.759B | 0.00 |
IRadimed (IRMD) | United States | $0.735B | 37.29 |
Beta Bionics (BBNX) | United States | $0.636B | 0.00 |
AxoGen (AXGN) | United States | $0.612B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.548B | 8.53 |
OrthoPediatrics (KIDS) | United States | $0.541B | 0.00 |
Semler Scientific (SMLR) | United States | $0.505B | 10.86 |
Pacific Biosciences Of California (PACB) | United States | $0.462B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.452B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.422B | 9.82 |
Delcath Systems (DCTH) | United States | $0.380B | 0.00 |
AngioDynamics (ANGO) | United States | $0.371B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.352B | 0.00 |
RxSight (RXST) | United States | $0.318B | 0.00 |
Neuronetics (STIM) | United States | $0.296B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
NeuroPace (NPCE) | United States | $0.288B | 0.00 |
908 Devices (MASS) | United States | $0.249B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.246B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.240B | 14.52 |
CVRx (CVRX) | United States | $0.215B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.202B | 0.00 |
Sight Sciences (SGHT) | United States | $0.179B | 0.00 |
Inogen (INGN) | United States | $0.177B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.164B | 0.00 |
LENSAR (LNSR) | United States | $0.154B | 0.00 |
Accuray (ARAY) | United States | $0.154B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.121B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.119B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.117B | 0.00 |
Anteris Technologies Global (AVR) | Australia | $0.115B | 0.00 |
Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.088B | 53.30 |
EnVVeno Medical (NVNO) | United States | $0.086B | 0.00 |
Hyperfine (HYPR) | United States | $0.082B | 0.00 |
InspireMD (NSPR) | United States | $0.075B | 0.00 |
Spectral AI (MDAI) | United States | $0.064B | 0.00 |
Positron (POSC) | United States | $0.060B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.054B | 0.00 |
QT Imaging Holdings (QTIH) | United States | $0.052B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
Precision Optics (POCI) | United States | $0.037B | 0.00 |
Envoy Medical (COCH) | United States | $0.032B | 0.00 |
DarioHealth (DRIO) | United States | $0.024B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
NexGel (NXGL) | United States | $0.018B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.013B | 0.00 | |
PAVmed (PAVM) | United States | $0.010B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
Tenon Medical (TNON) | United States | $0.008B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
Venus Concept (VERO) | Canada | $0.003B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Nuwellis (NUWE) | United States | $0.001B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 14.94 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |